Jenny Chow

• Successful product launches in respiratory biologic, transforming the treatment of severe asthma
• Account management of target offices: IDN, infusion centers, and key accounts in the Mid-Atlantic. High level of territory planning and successful strategy execution. Collaborated with sales teams and reimbursement mangers to understand patient pathways to access
• Educated customers on buy and bill process, prior authorization & appeal requirements, HUB support, and patient assistance program offerings
• Experienced with products dispensed by specialty pharmacy, PBM and Part D coverage
• Nominated by manager for two access leadership roles- FIT (field input team), a liaison between brand/market access and district/region/nation
• Developed, implemented and expanded site of care options for providers to augment patient access to approved products
• Excellent grasp in various systems including HUB TAR & SP TAR reports, SOB and MMIT which are used to understand and pull through the patient from start through fulfillment
• Expert knowledge on formulary access, benefit designs, and local payers
• Self learning: ACTO and FRM Prep program modules
• Developed manage care scenarios & training videos for field sales
• #13 COE rank (150 representatives) first year of Fasenra launch 2018; Top 20% Nation 2019; Top 12% Nation 2021
• Promoted to Senior Executive Sales Specialist; highest band level 2021
• #13 COE rank (180 representatives) first year of Tezspire launch 2022
• “Exceptional Contribution” 2022 & 2023
• Received National Humble Award 2023- voted by my peers
• Access Strategy Rotation for Tezspire Brand Team 2024

• Launched atypical antipsychotic long acting injectable therapy for schizophrenia to psychiatrists, hospitals, and mental health clinics
• Solo territory employing account management skills and market analysis
• Education of key players of payer landscape and enrollment process
• Implemented tactics in offices to ensure successful referral process
• #3 Region (29 representatives) 2013
• #5 Region (43 representatives) 2015
• #3 Nation (257 representatives); Leader’s Award (top 10% Nation) 2016
• #10 in Region (25 representatives); #35 Nation (205 representatives) 2017

• Promote, distribute, and sell Sunovion’s line of respiratory products across Allergy, Pulmonary, Otolaryngology, and primary care offices
• Top 10% Nation (363 representatives) within first year on territory

Cholesterol Management Sales Force

Senior Specialty Representative

• Implement early awareness and acceptance of cardiovascular products with key thought leaders
• Routinely collaborate with other sales force within Merck (vaccine, hospital, and Schering Plough) to ensure an unified approach to local geographies’ business needs
• Vice President's Award: #2 Nation (200 representatives) 2009
• Promoted to Senior Specialty Representative 2005
• Promoted to Specialty Representative in Northern Virginia 2004
• Successful launch of Vioxx; achieved market share and growth greater than both national and regional averages for 5 years
• District mentor and regional trainer 2000-2004
• Nominated to represent District in the Regional Diversity Action Committee 2000-2003
• Promoted to Senior Representative in just three years with Merck 2002
• Vice President’s Award, most prestigious sales award, top 10% Nation 2001